Hosted on MSN39m
FDA beats EMA to most approved new drugs in 2024On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Analyst David Risinger of Leerink Partners reiterated a Buy rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target ...
Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...
This double-digit growth in new drug sales showcases the company's ability to successfully commercialize cutting-edge ...
CNBC on MSN9d
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketThe FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
AbbVie's $3.5 Billion Blow: Can Bold Bets Revive Its Profit Forecasts?
Not too much should be read into 33-year-old Coventry-born forward Jamie Paterson training with The Sky Blues, with Lampard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback